Consort Medical plc (LON:CSRT) insider Ian James Nicholson purchased 1,350 shares of the business’s stock in a transaction on Friday, August 9th. The stock was purchased at an average cost of GBX 736 ($9.62) per share, for a total transaction of £9,936 ($12,983.14).
LON CSRT opened at GBX 736 ($9.62) on Friday. The firm’s fifty day simple moving average is GBX 791.54 and its two-hundred day simple moving average is GBX 874.11. The company has a current ratio of 1.63, a quick ratio of 1.04 and a debt-to-equity ratio of 46.56. Consort Medical plc has a 12-month low of GBX 700 ($9.15) and a 12-month high of GBX 1,270 ($16.59). The firm has a market capitalization of $363.32 million and a P/E ratio of 34.72.
The company also recently declared a dividend, which will be paid on Friday, October 25th. Shareholders of record on Thursday, September 19th will be issued a GBX 13.80 ($0.18) dividend. This is a positive change from Consort Medical’s previous dividend of $7.60. This represents a yield of 1.53%. The ex-dividend date of this dividend is Thursday, September 19th. Consort Medical’s payout ratio is currently 1.32%.
Consort Medical Company Profile
Consort Medical plc operates as a one-stop developer and manufacturer of drugs and premium drug delivery devices. It operates through two divisions, Bespak and Aesica. The company provides various life improving treatments to patients across worldwide through the design, development, and manufacture of medical devices for inhaled, injectable, nasal, and ocular drug delivery, as well as point of care diagnostics products.
Read More: What are the most popular ETFs
Receive News & Ratings for Consort Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Consort Medical and related companies with MarketBeat.com's FREE daily email newsletter.